These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Serological markers to differentiate between ulcerative colitis and Crohn's disease. Oudkerk Pool M; Bouma G; Meuwissen SG; von Blomberg BM; van de Merwe JP; Devillé WL; Fonk JC; Peña AS J Clin Pathol; 1995 Apr; 48(4):346-50. PubMed ID: 7615855 [TBL] [Abstract][Full Text] [Related]
67. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. Canani RB; de Horatio LT; Terrin G; Romano MT; Miele E; Staiano A; Rapacciuolo L; Polito G; Bisesti V; Manguso F; Vallone G; Sodano A; Troncone R J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):9-15. PubMed ID: 16385247 [TBL] [Abstract][Full Text] [Related]
68. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Gupta SK; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR Inflamm Bowel Dis; 2004 May; 10(3):240-4. PubMed ID: 15290918 [TBL] [Abstract][Full Text] [Related]
69. Clinical indications of the use of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in the evaluation of inflammatory bowel disease at an Academic Medical Center. Gupta A; Derbes C; Sellin J Inflamm Bowel Dis; 2005 Oct; 11(10):898-902. PubMed ID: 16189419 [TBL] [Abstract][Full Text] [Related]
70. Antibody markers in the diagnosis of inflammatory bowel disease. Mitsuyama K; Niwa M; Takedatsu H; Yamasaki H; Kuwaki K; Yoshioka S; Yamauchi R; Fukunaga S; Torimura T World J Gastroenterol; 2016 Jan; 22(3):1304-10. PubMed ID: 26811667 [TBL] [Abstract][Full Text] [Related]
73. Serological antibodies in inflammatory bowel disease: a systematic review. Prideaux L; De Cruz P; Ng SC; Kamm MA Inflamm Bowel Dis; 2012 Jul; 18(7):1340-55. PubMed ID: 22069240 [TBL] [Abstract][Full Text] [Related]
74. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis. Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154 [TBL] [Abstract][Full Text] [Related]
75. High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Yu JE; De Ravin SS; Uzel G; Landers C; Targan S; Malech HL; Holland SM; Cao W; Harpaz N; Mayer L; Cunningham-Rundles C Clin Immunol; 2011 Jan; 138(1):14-22. PubMed ID: 20956091 [TBL] [Abstract][Full Text] [Related]
76. ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease? Zhou G; Song Y; Yang W; Guo Y; Fang L; Chen Y; Liu Z Dig Dis; 2016; 34(1-2):90-7. PubMed ID: 26982193 [TBL] [Abstract][Full Text] [Related]
78. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Allenspach K; Luckschander N; Styner M; Seibold F; Doherr M; Aeschbach D; Gaschen F Am J Vet Res; 2004 Sep; 65(9):1279-83. PubMed ID: 15478778 [TBL] [Abstract][Full Text] [Related]
79. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Sendid B; Colombel JF; Jacquinot PM; Faille C; Fruit J; Cortot A; Lucidarme D; Camus D; Poulain D Clin Diagn Lab Immunol; 1996 Mar; 3(2):219-26. PubMed ID: 8991640 [TBL] [Abstract][Full Text] [Related]
80. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Lidar M; Langevitz P; Barzilai O; Ram M; Porat-Katz BS; Bizzaro N; Tonutti E; Maieron R; Chowers Y; Bar-Meir S; Shoenfeld Y Ann N Y Acad Sci; 2009 Sep; 1173():640-8. PubMed ID: 19758210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]